Food and Drug Regulations (C.R.C., c. 870)

Regulations are current to 2013-06-10 and last amended on 2013-05-31. Previous Versions

Schedule F Drugs

  •  (1) In this section and sections C.01.041.1 to C.01.046, “Schedule F Drug” means a drug listed or described in Schedule F to these Regulations.

  • (1.1) Subject to sections C.01.043 and C.01.046, no person shall sell a substance containing a Schedule F Drug unless

    • (a) the sale is made pursuant to a verbal or written prescription received by the seller; and

    • (b) where the prescription has been transferred to the seller under section C.01.041.1, the requirements of section C.01.041.2 have been complied with.

  • (2) Where the prescription for a Schedule F Drug is written, the person selling the drug shall retain the prescription for at least two years from the date of filling.

  • (3) Where the prescription for a Schedule F Drug is verbal, the person to whom the prescription is communicated by the practitioner shall forthwith reduce the prescription to writing and the person selling the drug shall retain that written prescription for a period of at least two years from the date of filling.

  • (4) The person reducing a verbal prescription to writing shall indicate on the written prescription

    • (a) the date and number of the prescription;

    • (b) the name and address of the person for whose benefit the prescription is given;

    • (c) the proper name, common name or brand name of the specified drug and the quantity thereof;

    • (d) his name and the name of the practitioner who issued the prescription; and

    • (e) the directions for use given with the prescription, including whether or not the practitioner authorized the refilling of the prescription and, if the prescription is to be refilled, the number of times it may be refilled.

  • (5) Subsections (1.1) to (4) do not apply to a substance containing

    • (a) chloral hydrate in preparations for external use, where it constitutes not more than one per cent of the substance, or

    • (b) hexachlorophene and its salts, where it constitutes not more than 0.75 per cent of the substance, calculated as hexachlorophene.

  • SOR/78-424, s. 2;
  • SOR/80-543, s. 3;
  • SOR/93-202, s. 6;
  • SOR/93-407, s. 2.

 A pharmacist may transfer to another pharmacist a prescription for a Schedule F Drug.

  • SOR/78-424, s. 3.
  •   A pharmacist to whom a prescription has been transferred under section C.01.041.1 shall not sell a drug pursuant thereto until

    • (a) he has obtained from the pharmacist transferring the prescription his name and address, the number of authorized refills remaining and the date of the last refill; and

    • (b) he has

      • (i) received a copy of the prescription as written by the practitioner or as reduced to writing as required by subsections C.01.041(3) and (4), as the case may be, or

      • (ii) where the prescription has been transferred to him verbally, reduced the prescription to writing indicating therein the information specified in subsection C.01.041(4).

  •  

  • SOR/78-424, s. 3.